New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
New Delhi: President Droupadi Murmu on Wednesday attended the award ceremony of the 65th National…
New Delhi: Union Agriculture and Farmers’ Welfare Minister Shivraj Singh Chouhan has called for developing…
Bhubaneswar: Odisha Chief Secretary Anu Garg has called for expanding livelihood opportunities for rural families…
Bhubaneswar: Odisha Chief Secretary Anu Garg has directed all concerned departments and District Collectors to…
Bhubaneswar: Higher secondary schools across Odisha must install CCTV cameras in examination halls and other…
Cuttack: Remembering police personnel who made the ultimate sacrifice in the service of the nation,…
